Rocket Pharmaceuticals (RCKT) Cash from Financing (Quarterly): 0.15M

Rocket Pharmaceuticals, Inc. (RCKT)

2.18 -0.18 (-7.63%) USD | NASDAQ | Oct 16, 16:00

2.21 +0.03 (+1.38%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2013. Start Trial.

Date	Value
June 30, 2026	0.15M
March 31, 2026	-0.001M
December 31, 2025	0.002M
September 30, 2025	-0.059M
June 30, 2025	0.228M
March 31, 2025	0.012M
December 31, 2024	182.86M
September 30, 2024	0.20M
June 30, 2024	1.559M
March 31, 2024	1.211M
December 31, 2023	0.421M
September 30, 2023	189.52M
June 30, 2023	0.219M
March 31, 2023	18.38M
December 31, 2022	108.48M
September 30, 2022	29.57M
June 30, 2022	17.29M
March 31, 2022	0.121M
December 31, 2021	-0.307M
September 30, 2021	27.10M
June 30, 2021	2.362M
March 31, 2021	8.729M
December 31, 2020	286.44M
September 30, 2020	1.08M
June 30, 2020	0.997M

Date	Value
March 31, 2020	0.034M
December 31, 2019	92.41M
September 30, 2019	0.031M
June 30, 2019	85.35M
March 31, 2019	0.00
December 31, 2018	74.84M
September 30, 2018	0.149M
June 30, 2018	0.00
March 31, 2018	78.52M
December 31, 2017	0.00
September 30, 2017	-0.039M
June 30, 2017	3.896M
March 31, 2017	21.55M
December 31, 2016	0.213M
September 30, 2016	48.69M
June 30, 2016	4.182M
March 31, 2016	0.00
December 31, 2015	0.073M
September 30, 2015	73.97M
June 30, 2015	-0.04M
March 31, 2015	51.51M
December 31, 2014	1.255M
September 30, 2014
June 30, 2014
March 31, 2014	0.00

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks